lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
cupric bromide basic information |
product name: | cupric bromide |
synonyms: | copperbromide(cubr2);copperdibromide;cupric bromide;copper(ii) bromide;copper bromide;copper(+2)bromide;copperic bromide ;copper(ⅱ) bromide |
cas: | 7789-45-9 |
mf: | br2cu |
mw: | 223.35 |
einecs: | 232-167-2 |
product categories: | inorganics;metal halide |
mol file: | 7789-45-9.mol |
cupric bromide chemical properties |
mp | 498 °c(lit.) |
bp | 900 °c |
density | 4.77 g/ml at 25 °c(lit.) |
fp | 900°c |
water solubility | soluble |
sensitive | hygroscopic |
merck | 14,2629 |
stability: | stable. incompatible with alkali metals, moisture. reacts violently with potassium. |
cas database reference | 7789-45-9(cas database reference) |
nist chemistry reference | copper(ii) dibromide(7789-45-9) |
safety information |
hazard codes | c,xi |
risk statements | 22-34-36/37/38 |
safety statements | 26-36/37/39-45-24/25 |
ridadr | un 3260 8/pg 3 |
wgk germany | 3 |
hazardclass | 8 |
packinggroup | iii |
hazardous substances data | 7789-45-9(hazardous substances data) |